Wikidata

(Q61965921)

English

Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis

clinical trial

In more languages

Statements

short name
MIRROR (English)
0 references
title
A Randomized, Double-blind, Placebo-controlled, Parallel-Group, Dose-Ranging Study to Investigate the MRI Efficacy and Safety of Six Months' Administration of Ofatumumab in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
sponsor
GSK
0 references
country
Bulgaria
0 references
Canada
0 references
Denmark
0 references
Germany
0 references
Italy
0 references
Netherlands
0 references
Norway
0 references
Spain
0 references
start time
1 November 2011
0 references
end time
23 August 2013
0 references
number of participants
232
0 references
research site
GSK
0 references
minimum age
18 year
0 references
maximum age
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61965921&oldid=2083568118"